e-learning
resources
Vienna 2012
Monday, 03.09.2012
Trials in asthma: asthma exacerbations and severe asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term efficacy of QMF149 in persistent asthma
R. Beasley, B. Lanier, Z. Márk, A. Moton, H.J. Kim, B. Hederer (Wellington, New Zealand; Fort Worth, East Hanover, United States Of America; Törökbálint, Hungary; Basel, Switzerland)
Source:
Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Session:
Trials in asthma: asthma exacerbations and severe asthma
Session type:
Poster Discussion
Number:
1791
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Beasley, B. Lanier, Z. Márk, A. Moton, H.J. Kim, B. Hederer (Wellington, New Zealand; Fort Worth, East Hanover, United States Of America; Törökbálint, Hungary; Basel, Switzerland). Long-term efficacy of QMF149 in persistent asthma. Eur Respir J 2012; 40: Suppl. 56, 1791
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Efficacy of the long-term therapy with simbicort in children with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005
Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 379s
Year: 2004
Long-term effectiveness of PEF-guided self-management in asthma
Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma
Year: 2007
Long-term treatment of aspirin-intolerante asthma with budesonide. Effectivity and safety
Source: Eur Respir J 2001; 18: Suppl. 33, 156s
Year: 2001
Comparable efficacy of calcilytic and corticosteroid in short-term and long-term allergic asthma models in vivo
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Immunological effectiveness of atorvastatin in complex therapy of severe persistent bronchial asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Early treatment response may predict long-term mepolizumab benefit in severe asthma
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008
The efficacy of omalizumab in severe in asthma after treatment withdrawal
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Long-term benefits of pulmonary rehabilitation in patients with chronic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 454s
Year: 2002
Assesment of long-term omalizumab treatment in severe allergic asthma
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012
Efficacy and safety of long-term therapy with Salamol combined with Beclason
versus
Salamol only in patients with mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002
Real-life long-term omalizumab therapy in children with severe allergic asthma
Source: Eur Respir J 2015; 46: 856-859
Year: 2015
Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
Long-term safety of inhaled formoterol in adult asthma patients
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Long-term effectiveness of a staged assessment for paediatric problematic severe asthma
Source: Eur Respir J 2012; 40: 264-267
Year: 2012
Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept